Clinical Trials Browser

Phase 2 × NIH × Docetaxel × Clear all

NCT02642042 2026-05-29

Trametinib and Docetaxel in Treating Patients With Recurrent or Stage IV KRAS Mutation Positive Non-small Cell Lung Cancer

Phase 2 Active not recruiting

60 enrolled 24 charts

Carcinoma, Non-Small-Cell Lung

NCT04310007 2026-05-29

Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung Cancer

Phase 2 Active not recruiting

Lung Neoplasms

NCT05836584 2026-05-28

Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastroesophageal Junction (GEJ) Cancer

Phase 2 Active not recruiting

Gastrointestinal

Clinical Stage I Gastric Cancer AJCC v8

NCT00334815 2026-05-26

Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery

Phase 2 Active not recruiting

29 enrolled 10 charts

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar

NCT02649855 2026-04-29

Docetaxel and PROSTVAC for Metastatic Castration-Sensitive Prostate Cancer

Phase 2 Completed

74 enrolled 15 charts

Prostatic Neoplasms

NCT06223568 2026-04-28

Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) Cancer

Phase 2 Recruiting

Squamous Cell Carcinoma of Head and Neck, Oropharyngeal Neoplasms

NCT03517969 2026-04-23

M6620 and Carboplatin With or Without Docetaxel in Treating Patients With Metastatic Castration-Resistant Prostate Cancer

Phase 2 Active not recruiting

73 enrolled 14 charts

Prostatic Neoplasms

NCT00020046 2023-10-31

Docetaxel With or Without Thalidomide in Treating Patients With Metastatic Prostate Cancer

Phase 2 Completed

Neoplasms, Prostatic Neoplasms, Genetic Diseases, Inborn

NCT01196429 2019-08-08

Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III-IV Clear Cell Ovarian Cancer

Phase 2 Completed

90 enrolled 10 charts

Ovarian Neoplasms

NCT00942578 2018-10-11

A Phase 2 Trial of Bevacizumab, Lenalidomide, Docetaxel, and Prednisone (ART-P) for Treatment of Metastatic Castrate-Resistant Prostate Cancer

Phase 2 Completed

63 enrolled 23 charts

Prostatic Neoplasms

NCT00527124 2018-08-09

Docetaxel and Prednisone With or Without Cediranib in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

Phase 2 Terminated

57 enrolled 12 charts

Prostatic Neoplasms

NCT01935947 2018-07-27

Azacitidine and Entinostat Before Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer

Phase 2 Terminated

17 enrolled 10 charts

Carcinoma, Non-Small-Cell Lung

NCT00089609 2018-04-20

Docetaxel, Thalidomide, Prednisone, and Bevacizumab to Treat Metastatic Prostate Cancer

Phase 2 Completed

73 enrolled 16 charts

Neoplasms, Prostatic Neoplasms

NCT00362882 2017-12-05

Docetaxel and Bortezomib in Treating Patients With Progressive or Recurrent Non-Small Cell Lung Cancer

Phase 2 Completed

81 enrolled 10 charts

Carcinoma, Non-Small-Cell Lung

NCT01145508 2017-09-19

Docetaxel and Prednisone With or Without Vaccine Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Phase 2 Terminated

10 enrolled 6 charts

Prostatic Neoplasms

NCT00963807 2017-03-17

A Comparison of FLT to FDG PET/CT in the Early Assessment of Chemotherapy Response in Stage IB-IIIA Resectable NSCLC

Phase 2 Completed

26 enrolled 10 charts

Carcinoma, Non-Small-Cell Lung

NCT00253370 2014-11-24

Sorafenib, Docetaxel, and Cisplatin in Treating Patients With Metastatic or Advanced Gastric or Gastroesophageal Junction Cancer

Phase 2 Completed

44 enrolled 8 charts

Gastrointestinal

Stomach Neoplasms

NCT00179309 2014-07-15

Docetaxel Alone or in Combination With Vaccine to Treat Breast Cancer

Phase 2 Completed

48 enrolled 11 charts

Breast Neoplasms

NCT00331682 2014-05-28

Docetaxel and Flavopiridol in Treating Patients With Refractory Metastatic Pancreatic Cancer

Phase 2 Completed

10 enrolled 9 charts

Gastrointestinal

Pancreatic Neoplasms

NCT00004888 2014-05-23

Combination Chemotherapy With or Without Trastuzumab in Treating Women With Metastatic Breast Cancer

Phase 2 Completed

84 enrolled 9 charts

Breast Neoplasms

NCT00514293 2014-01-10

Bexarotene, Tretinoin, and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00003066 2014-01-06

Docetaxel Combined With Estramustine in Treating Women With Metastatic Breast Cancer

Phase 2 Unknown

Breast Neoplasms

NCT00003560 2014-01-06

Docetaxel Plus Carboplatin in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Phase 2 Unknown

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT00012311 2014-01-06

Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Chemotherapy Alone in Treating Women With Stage IV Breast Cancer

Phase 2 Unknown

Breast Neoplasms

NCT00006215 2013-12-19

Docetaxel and Vinorelbine Plus Filgrastim in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00003562 2013-12-04

Docetaxel Plus Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Phase 2 Unknown

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00005958 2013-12-04

Combination Chemotherapy Plus Filgrastim in Treating Patients With Locally Recurrent or Advanced Urothelium Cancer

Phase 2 Unknown

Urinary Bladder Neoplasms

NCT00005960 2013-12-04

Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

Phase 2 Unknown

Pain, Prostatic Neoplasms

NCT00321633 2013-08-26

Carboplatin or Docetaxel in Treating Women With Metastatic Genetic Breast Cancer

Phase 2 Completed

BreastGynecologic

Breast Neoplasms, Hereditary Breast and Ovarian Cancer Syndrome

NCT00026078 2013-08-07

Docetaxel and Ifosfamide in Treating Women With Metastatic Breast Cancer

Phase 2 Unknown

Breast Neoplasms

NCT00554918 2013-08-07

Docetaxel and Prednisolone With or Without Zoledronic Acid and/or Strontium Chloride Sr 89 in Treating Patients With Prostate Cancer Metastatic to Bone That Has Not Responded to Hormone Therapy

Phase 2 Completed

Neoplasm Metastasis, Prostatic Neoplasms

NCT00003445 2013-06-26

Docetaxel in Treating Patients With Advanced Cancer of the Cervix

Phase 2 Completed

Uterine Cervical Neoplasms

NCT00138242 2013-06-26

Docetaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer

Phase 2 Completed

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00003172 2013-06-21

Comparison of Combination Chemotherapy Regimens in Treating Patients With Advanced Stomach Cancer

Phase 2 Completed

Gastrointestinal

Stomach Neoplasms

NCT00045227 2013-06-19

Vaccine Therapy With or Without Docetaxel in Treating Patients With Metastatic Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms

NCT00016107 2013-06-05

Combination Chemotherapy Plus Bevacizumab in Treating Patients With Metastatic Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms

NCT00055861 2013-06-04

Bevacizumab and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer

Phase 2 Completed

Breast Neoplasms

NCT00118183 2013-06-04

Docetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Phase 2 Completed

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Pleural Effusion, Malignant

NCT00004906 2013-05-30

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer

Phase 2 Completed

Breast Neoplasms

NCT00044993 2013-05-30

Chemotherapy Combined With Gene Therapy in Treating Patients Who Have Stage III or Stage IV Breast Cancer

Phase 2 Completed

Breast Neoplasms, Breast Neoplasms, Male

NCT00046826 2013-04-04

Docetaxel, Estramustine, and Thalidomide in Treating Patients With Prostate Cancer Previously Treated With Hormone Therapy

Phase 2 Completed

Prostatic Neoplasms

NCT00243113 2013-03-26

Docetaxel and Radiation Therapy in Treating Patients With Stage II or Stage III Cancer of the Larynx or Hypopharynx

Phase 2 Completed

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT00005908 2013-03-19

Primary Chemotherapy With Docetaxel-Capecitabine and Doxorubicin-Cyclophosphamide in Breast Cancer

Phase 2 Completed

30 enrolled 12 charts

Breast Neoplasms

NCT00002825 2013-02-05

Docetaxel in Treating Children With Recurrent Solid Tumors

Phase 2 Completed

Familial ependymoma, Astrocytoma, Medulloblastoma, Neuroblastoma, Sarcoma, Osteosarcoma, Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral

NCT00069160 2012-10-12

Tariquidar and Docetaxel to Treat Patients With Lung, Ovarian, Renal and Cervical Cancer

Phase 2 Completed

48 enrolled 13 charts

GenitourinaryGynecologicThoracic

Uterine Cervical Neoplasms, Kidney Neoplasms, Lung Neoplasms, Ovarian Neoplasms

NCT00083005 2012-03-15

Docetaxel, Estramustine, and Thalidomide in Treating Patients With Androgen-Independent Metastatic Adenocarcinoma of the Prostate

Phase 2 Completed

Prostatic Neoplasms

NCT00083083 2011-03-01

Fludeoxyglucose F18 Positron Emission Tomography Imaging In Assessing Patients Before and After Treatment for Locally Advanced Non-Small Cell Lung Cancer

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00625937 2011-02-28

Docetaxel and S-1 Followed By Radiation Therapy and Low-Dose Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer

Phase 2 Unknown

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Tongue Neoplasms

NCT00736814 2011-02-24

First-Line Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00398489 2010-11-09

Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery

Phase 2 Unknown

Breast Neoplasms, Inflammatory Breast Neoplasms